In only two studies (49,66), for the examination of the evolution of coagulation, fibrinogen and endothelial function biomarkers (49), and the kinetics of serum albumin in patients critically ill with COVID-19(66), control groups were included. The gene discussed is ALB; the disease is COVID-19.